Interestingly, a recent study demonstrated that TIGIT signaling enhances the function of FOXP3+ Tregs from patients with multiple sclerosis by upregulating Foxo1 that blocks T-bet expression and limits IFN-γ secretion (59). This evidence concerns the gene IFNG and multiple sclerosis.